158 related articles for article (PubMed ID: 28881271)
1. Factor VII activating protease (FSAP) regulates the expression of inflammatory genes in vascular smooth muscle and endothelial cells.
Byskov K; Boettger T; Ruehle PF; Nielsen NV; Etscheid M; Kanse SM
Atherosclerosis; 2017 Oct; 265():133-139. PubMed ID: 28881271
[TBL] [Abstract][Full Text] [Related]
2. Factor VII-activating protease deficiency promotes neointima formation by enhancing leukocyte accumulation.
Daniel JM; Reichel CA; Schmidt-Woell T; Dutzmann J; Zuchtriegel G; Krombach F; Herold J; Bauersachs J; Sedding DG; Kanse SM
J Thromb Haemost; 2016 Oct; 14(10):2058-2067. PubMed ID: 27431088
[TBL] [Abstract][Full Text] [Related]
3. Protease activated receptors (PAR)-1 and -2 mediate cellular effects of factor VII activating protease (FSAP).
Byskov K; Le Gall SM; Thiede B; Camerer E; Kanse SM
FASEB J; 2020 Jan; 34(1):1079-1090. PubMed ID: 31914657
[TBL] [Abstract][Full Text] [Related]
4. The G534E polymorphism of the gene encoding the factor VII-activating protease is associated with cardiovascular risk due to increased neointima formation.
Sedding D; Daniel JM; Muhl L; Hersemeyer K; Brunsch H; Kemkes-Matthes B; Braun-Dullaeus RC; Tillmanns H; Weimer T; Preissner KT; Kanse SM
J Exp Med; 2006 Dec; 203(13):2801-7. PubMed ID: 17145954
[TBL] [Abstract][Full Text] [Related]
5. Factor VII-activating protease (FSAP) inhibits growth factor-mediated cell proliferation and migration of vascular smooth muscle cells.
Kannemeier C; Al-Fakhri N; Preissner KT; Kanse SM
FASEB J; 2004 Apr; 18(6):728-30. PubMed ID: 14977886
[TBL] [Abstract][Full Text] [Related]
6. Factor VII-activating protease (FSAP): vascular functions and role in atherosclerosis.
Kanse SM; Parahuleva M; Muhl L; Kemkes-Matthes B; Sedding D; Preissner KT
Thromb Haemost; 2008 Feb; 99(2):286-9. PubMed ID: 18278176
[TBL] [Abstract][Full Text] [Related]
7. Factor VII activating protease (FSAP) exerts anti-inflammatory and anti-fibrotic effects in liver fibrosis in mice and men.
Borkham-Kamphorst E; Zimmermann HW; Gassler N; Bissels U; Bosio A; Tacke F; Weiskirchen R; Kanse SM
J Hepatol; 2013 Jan; 58(1):104-11. PubMed ID: 22989567
[TBL] [Abstract][Full Text] [Related]
8. Deficiency of Factor VII activating protease alters the outcome of ischemic stroke in mice.
Joshi AU; Orset C; Engelhardt B; Baumgart-Vogt E; Gerriets T; Vivien D; Kanse SM
Eur J Neurosci; 2015 Apr; 41(7):965-75. PubMed ID: 25615590
[TBL] [Abstract][Full Text] [Related]
9. Nucleic acids potentiate Factor VII-activating protease (FSAP)-mediated cleavage of platelet-derived growth factor-BB and inhibition of vascular smooth muscle cell proliferation.
Shibamiya A; Muhl L; Tannert-Otto S; Preissner KT; Kanse SM
Biochem J; 2007 May; 404(1):45-50. PubMed ID: 17300216
[TBL] [Abstract][Full Text] [Related]
10. High negative charge-to-size ratio in polyphosphates and heparin regulates factor VII-activating protease.
Muhl L; Galuska SP; Oörni K; Hernández-Ruiz L; Andrei-Selmer LC; Geyer R; Preissner KT; Ruiz FA; Kovanen PT; Kanse SM
FEBS J; 2009 Sep; 276(17):4828-39. PubMed ID: 19664058
[TBL] [Abstract][Full Text] [Related]
11. Cellular effects of factor VII activating protease (FSAP).
Byskov K; Etscheid M; Kanse SM
Thromb Res; 2020 Apr; 188():74-78. PubMed ID: 32087413
[TBL] [Abstract][Full Text] [Related]
12. Expression of the Marburg I Single Nucleotide Polymorphism (MI-SNP) and the Marburg II Single Nucleotide Polymorphism (MII-SNP) of the Factor VII-Activating Protease (FSAP) Gene and Risk of Coronary Artery Disease (CAD): A Pilot Study in a Single Population.
Parahuleva MS; Schieffer B; Klassen M; Worsch M; Parviz B; Hölschermann H
Med Sci Monit; 2018 Jun; 24():4271-4278. PubMed ID: 29927903
[TBL] [Abstract][Full Text] [Related]
13. VEGF-A-Cleavage by FSAP and Inhibition of Neo-Vascularization.
Uslu Ö; Herold J; Kanse SM
Cells; 2019 Nov; 8(11):. PubMed ID: 31698750
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of PDGF-BB by Factor VII-activating protease (FSAP) is neutralized by protease nexin-1, and the FSAP-inhibitor complexes are internalized via LRP.
Muhl L; Nykjaer A; Wygrecka M; Monard D; Preissner KT; Kanse SM
Biochem J; 2007 Jun; 404(2):191-6. PubMed ID: 17298300
[TBL] [Abstract][Full Text] [Related]
15. Factor VII activating protease. Single nucleotide polymorphisms light the way.
Kanse SM; Etscheid M
Hamostaseologie; 2011 Aug; 31(3):174-6, 177-8. PubMed ID: 21655671
[TBL] [Abstract][Full Text] [Related]
16. Regulation of monocyte/macrophage function by factor VII activating protease (FSAP).
Parahuleva MS; Maj R; Hölschermann H; Parviz B; Abdallah Y; Erdogan A; Tillmanns H; Kanse SM
Atherosclerosis; 2013 Oct; 230(2):365-72. PubMed ID: 24075769
[TBL] [Abstract][Full Text] [Related]
17. Changes in factor VII-activating protease in a bleomycin-induced lung injury rat model and its influence on human pulmonary fibroblasts in vitro.
Mu E; Liu X; Chen S; Zhi L; Li X; Xu X; Ma X
Int J Mol Med; 2010 Oct; 26(4):549-55. PubMed ID: 20818495
[TBL] [Abstract][Full Text] [Related]
18. The Marburg I polymorphism of factor VII activating protease is associated with low proteolytic and low pro-coagulant activity.
Etscheid M; Muhl L; Pons D; Jukema JW; König H; Kanse SM
Thromb Res; 2012 Dec; 130(6):935-41. PubMed ID: 22906531
[TBL] [Abstract][Full Text] [Related]
19. TRAF6-Mediated SM22α K21 Ubiquitination Promotes G6PD Activation and NADPH Production, Contributing to GSH Homeostasis and VSMC Survival In Vitro and In Vivo.
Dong LH; Li L; Song Y; Duan ZL; Sun SG; Lin YL; Miao SB; Yin YJ; Shu YN; Li H; Chen P; Zhao LL; Han M
Circ Res; 2015 Sep; 117(8):684-94. PubMed ID: 26291555
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide analysis of genetic determinants of circulating factor VII-activating protease (FSAP) activity.
Olsson M; Stanne TM; Pedersen A; Lorentzen E; Kara E; Martinez-Palacian A; Rønnow Sand NP; Jacobsen AF; Sandset PM; Sidelmann JJ; Engström G; Melander O; Kanse SM; Jern C
J Thromb Haemost; 2018 Oct; 16(10):2024-2034. PubMed ID: 30070759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
